181 related articles for article (PubMed ID: 26556943)
21. Challenges and priorities for surveillance of stillbirths: a report on two workshops.
Duke CW; Correa A; Romitti PA; Martin J; Kirby RS
Public Health Rep; 2009; 124(5):652-9. PubMed ID: 19753943
[TBL] [Abstract][Full Text] [Related]
22. Newborn screening for critical congenital heart disease: potential roles of birth defects surveillance programs--United States, 2010-2011.
Centers for Disease Control and Prevention
MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(42):849-53. PubMed ID: 23095953
[TBL] [Abstract][Full Text] [Related]
23. Random error and undercounting in birth defects surveillance data: implications for inference.
Correa-Villaseñor A; Satten GA; Rolka H; Langlois P; Devine O
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):610-6. PubMed ID: 14703782
[TBL] [Abstract][Full Text] [Related]
24. Using an existing birth defects surveillance program to enhance surveillance data on stillbirths.
Duke W; Gilboa SM
J Registry Manag; 2014; 41(1):13-8. PubMed ID: 24893183
[TBL] [Abstract][Full Text] [Related]
25. Using active birth defects surveillance programs to supplement data on fetal death reports: improving surveillance data on stillbirths.
Duke W; Williams L; Correa A
Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):799-804. PubMed ID: 18985684
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for waterborne-disease outbreaks--United States, 1999-2000.
Lee SH; Levy DA; Craun GF; Beach MJ; Calderon RL
MMWR Surveill Summ; 2002 Nov; 51(8):1-47. PubMed ID: 12489843
[TBL] [Abstract][Full Text] [Related]
27. Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles.
Lin AE; Rasmussen SA; Scheuerle A; Stevenson RE
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):69-75. PubMed ID: 19107957
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.
Van Naarden Braun K; Pettygrove S; Daniels J; Miller L; Nicholas J; Baio J; Schieve L; Kirby RS; Washington A; Brocksen S; Rahbar H; Rice C;
MMWR Surveill Summ; 2007 Feb; 56(1):29-40. PubMed ID: 17287716
[TBL] [Abstract][Full Text] [Related]
29. Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jan; 54(51):1301-5. PubMed ID: 16397457
[TBL] [Abstract][Full Text] [Related]
30. Registry data quality improvement by identifying discrepancies between assigned codes and text descriptions of birth defects.
Richardson SD; Fox DJ; Wittman B
J Registry Manag; 2013; 40(4):165-7. PubMed ID: 24625769
[TBL] [Abstract][Full Text] [Related]
31. Population and case-control surveillance in the search for environmental causes of birth defects.
Oakley GP
Public Health Rep; 1984; 99(5):465-8. PubMed ID: 6207556
[TBL] [Abstract][Full Text] [Related]
32. Congenital malformations surveillance: two American systems.
Edmonds LD; Layde PM; James LM; Flynt JW; Erickson JD; Oakley GP
Int J Epidemiol; 1981 Sep; 10(3):247-52. PubMed ID: 7287285
[TBL] [Abstract][Full Text] [Related]
33. Methods for surveillance of fetal alcohol syndrome: The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) - Arizona, Colorado, New York, 2009 - 2014.
O'Leary LA; Ortiz L; Montgomery A; Fox DJ; Cunniff C; Ruttenber M; Breen A; Pettygrove S; Klumb D; Druschel C; Frías JL; Robinson LK; Bertrand J; Ferrara K; Kelly M; Gilboa SM; Meaney FJ;
Birth Defects Res A Clin Mol Teratol; 2015 Mar; 103(3):196-202. PubMed ID: 25761572
[TBL] [Abstract][Full Text] [Related]
34. State electronic disease surveillance systems --- United States, 2007 and 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1421-3. PubMed ID: 22012115
[TBL] [Abstract][Full Text] [Related]
35. Birth defects surveillance in China.
Dai L; Zhu J; Liang J; Wang YP; Wang H; Mao M
World J Pediatr; 2011 Nov; 7(4):302-10. PubMed ID: 22015723
[TBL] [Abstract][Full Text] [Related]
36. Perspectives on public health workforce research.
Crawford CA; Summerfelt WT; Roy K; Chen ZA; Meltzer DO; Thacker SB
J Public Health Manag Pract; 2009 Nov; 15(6 Suppl):S5-S15. PubMed ID: 19829231
[TBL] [Abstract][Full Text] [Related]
37. Integration of DNA sample collection into a multi-site birth defects case-control study.
Rasmussen SA; Lammer EJ; Shaw GM; Finnell RH; McGehee RE; Gallagher M; Romitti PA; Murray JC;
Teratology; 2002 Oct; 66(4):177-84. PubMed ID: 12353214
[TBL] [Abstract][Full Text] [Related]
38. From cause to care: Triple surveillance for better outcomes in birth defects and rare diseases.
Botto LD; Mastroiacovo P
Eur J Med Genet; 2018 Sep; 61(9):551-555. PubMed ID: 29902591
[TBL] [Abstract][Full Text] [Related]
39. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
40. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
